Cagrilintide 5mg

Description

Cagrilintide 5mg for laboratory research

Cagrilintide is an amylin analogue supplied here as lyophilized powder with a 5mg label amount per vial. This product is intended for laboratory research. The 5mg designation describes an amount of material, not a concentration or an instruction for use.

Product details

• Product: Cagrilintide 5mg
• Label amount: 5mg per vial
• Form: Lyophilized powder
• Intended use: Laboratory research only

Batch-specific testing: CP-CAG5-2608

BT Labs tested batch CP-CAG5-2608 on August 28, 2026 and issued report COA261200-009 on September 2, 2026.

• Identification: FTIR result reports cagrilintide with excipients/fillers
• HPLC purity: 99.5%
• HPLC potency: 6.2mg

The measured potency is distinct from the 5mg label amount and from the purity percentage. These results apply to the submitted sample, not every vial or future batch. The report does not establish sterility or endotoxin status.

View the CP-CAG5-2608 COA summary. The linked image is page 1 of the laboratory report. Match the lot on your product to the documentation in the currently shipping COA database.

Research context and label amount

For educational background, see the Cagrilintide research overview. Research literature does not establish the performance of a supplied vial or replace its batch documentation.

ChoicePeps also lists Cagrilintide 10mg. Select the label amount required by your laboratory protocol and review the matching report for that strength. A different label amount does not establish a different purity or research outcome.

Storage and research use

Follow the product label and your laboratory handling protocol. Existing product guidance calls for refrigeration after preparation; no temperature-specific stability guarantee or shelf life is stated here.

For laboratory research only. Not for human or veterinary use, medical use or diagnostic applications. Read the research-use-only information.